Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Working Capital Changes (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Other Working Capital Changes for 17 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 133.33% to $300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 8.11% decrease, with the full-year FY2025 number at $3.4 million, down 8.11% from a year prior.
  • Other Working Capital Changes was $300000.0 for Q4 2025 at Myriad Genetics, down from $3.4 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $27.0 million in Q4 2021 to a low of -$11.2 million in Q3 2021.
  • A 5-year average of $760000.0 and a median of -$250000.0 in 2023 define the central range for Other Working Capital Changes.
  • Biggest YoY gain for Other Working Capital Changes was 13600.0% in 2021; the steepest drop was 1766.67% in 2021.
  • Myriad Genetics' Other Working Capital Changes stood at $27.0 million in 2021, then crashed by 75.56% to $6.6 million in 2022, then plummeted by 148.48% to -$3.2 million in 2023, then skyrocketed by 71.88% to -$900000.0 in 2024, then soared by 133.33% to $300000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Other Working Capital Changes are $300000.0 (Q4 2025), $3.4 million (Q3 2025), and -$800000.0 (Q2 2025).